AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1 https://www.biorxiv.org/content/10.1101/2022.12.16.520736v1?med=mas
AB668, a novel highly selective protein kinase CK2 inhibitor with a distinct anti-tumor mechanism as compared to CX-4945 and SGC-CK2-1 https://www.biorxiv.org/content/10.1101/2022.12.16.520736v1?med=mas